Conversations for Change – Hematology.org
Conversations for Change
Conversations for Change
A Roswell Park-led team uncovers beneficial effects of combining VEGFR-targeting TKIs with checkpoint inhibitors in new research.
There has been several developments in the KRAS inhibitor space, shaping the KRAS inhibitors of the future.
The SGO BRIDGES Research Initiative is a new, longitudinal clinical trials workshop for early career investigators with the aim of developing the next generation of…
An abstract is unavailable.
Cancer-associated fibroblasts (CAFs) exhibit spatial and functional diversity. Here, Niu et al. unveil SETD2’s function in lipid metabolism and CAF heterogeneity in pancreatic ductal adenocarcinoma. SETD2…
Anne Chiang, MD, PhD, discusses understanding the heterogeneity of SCLC to determine which patients will respond to targeted therapy.
A nipple delay is a procedure, typically used with a nipple-sparing mastectomy, that aims to save the nipple during breast cancer surgery.
It’s been inspiring – and humbling – to get to know the 40 young leaders in this year’s class. I recommend we all keep an…
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of…
Expert insights into the evolving therapeutic landscape for early-stage breast cancers, emphasizing targeted therapies and genomic testing for personalized treatment paradigms.